FDA Approves New Treatment Option for Patients with ALS ...Middle East

PR Newswire - News
FDA Approves New Treatment Option for Patients with ALS
SILVER SPRING, Md., Sept. 29, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease. "This approval provides another...

Hence then, the article about fda approves new treatment option for patients with als was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves New Treatment Option for Patients with ALS )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News